Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus placebo added to SGLT2 inhibitor therapy in adults with type 2 diabetes mellitus
MOH_2017-07-04_000563Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide + background therapy with Placebo + background therapy (2 arms). Started Nov 2016; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on MOH_2017-07-04_000563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-07-04_000563.